188 global investigators evaluate efficacy, coverage and opportunity for biologics and biosimilars in clinical development. Learn more in our infographic.
At Pharm-Olam, we believe that a high-quality feasibility assessment sets up your development program for future success. Learn more in our infographic.
Favorable conditions have put a spotlight on orphan drug clinical trials. We lay out tips to successfully conduct these trials and bring products to market.
Our research shows that Belgium is the #1 location in Europe for research activity. To learn more about its benefits of this region, view our infographic.
Based on the experience of our internal team, we have created a series of 13 study design and operational tips for your use. View them in our graphic.
Revised regulations in India warrant a fresh look into the region, as it could now be a viable country to run clinical trials. See why in our whitepaper.
Canada boasts a large population and favorable research conditions. See our infographic to learn what Canada has to offer as a site for clinical research.
Horizon 2020 promises to create more breakthroughs, discoveries, and world-firsts. Let Pharm-Olam help you be a part of it! Learn more in our graphic.
Pharm-Olam boasts over 20 years of experience in 15 therapeutic areas across 40 countries worldwide. Learn more about the leading mid-size global CRO.
Ukraine is a viable and proven market for clinical research. View our infographic to learn more about its advantages as a potential site for your study.
Participation in clinical trials is becoming more attractive in Turkey. Find out why you should consider this region for your study in our infographic.
Latin America offers easy access to a diverse patient population, along with many other benefits. View our infographic to learn more about this region.
With its expeditious trial approval and rapid patient enrollment, Belarus could be an excellent site for your next study. Find out more in our infographic.
Infectious disease is the third-largest therapeutic area of clinical research. Pharm-Olam is here to help you stand out and guide more successful studies.
Watch the video to learn more about our full service Anti-Infective clinical trial capabilities.
At Pharm-Olam, we’re here to help. Our experienced global staff has extensive experience in the processing and management of allergy clinical trials.
In the following webinar, we discuss the history, principles, and criteria of response evaluation in oncology trials. Click below to watch our presentation.
Rescue studies come in many forms. Here, we discuss our experience with over 75 rescue/supplementation studies and offer advice for smooth study transfer.
Antibiotic drug development is ever-changing. This webinar lays out the challenges to plan for during study design and tips to maximize its effectiveness.
Latin America offers a vast pool of diverse patients for your upcoming clinical trials. This webinar provides a wealth of information on the region’s advantages.
India’s regulatory environment has made it difficult to conduct clinical trials, but policy makers are improving these conditions. Learn more in our webinar.
In this Phase III study, Pharm-Olam partnered with a progressive company to help find a better solution for those suffering with this deadly, rare disease.
Allergic rhinitis affects between 10% and 25% of the worldwide population, and is observed most in ecologically unfavorable regions. See our study for more.
Glioblastoma / Anaplastic Astrocytoma is a brain tumor with very few available therapies. Learn more about our search for effective treatment options.
SLE is a notoriously difficult-to-diagnose autoimmune disorder with no known cure. Our study aimed to find a treatment for severe cases of the disorder.
In this webinar, our three speakers discuss how to manage global studies in emerging markets considering the CRO and Central Laboratory perspective.
Pharm-Olam was called on to rescue a Breast Cancer bioequivalence study. Learn how this transition process successfully supported the study sponsor.
Pharm-Olam provided clinical research services on a pediatric Respiratory Distress Syndrome study. Discover the unique challenges and solutions involved.
This webinar reviews tips on how technology can maximize success when running trials in emerging regions, as evidenced by Pharm-Olam’s partnership with ERT.
Pharm-Olam provided a complete enrollment solution for this ABSSSI study. Learn how Pharm-Olam’s efficiency allowed for a quick turnaround in this study.
Trial managers are expanding their efforts into non-traditional countries to obtain data. This webinar provides tips for successful trials in Ukraine.
Learn how Pharm-Olam overcame difficult enrollment challenges in a massive Systemic Lupus Erythematosus trial and earned high praise from the sponsor.
BA/BE studies require samples of the investigational product to be retained. Learn about Pharm-Olam’s automated solution that saves time and resources.
Ukraine boasts recruitment figures two times higher than in the U.S. and Western Europe. We go over important considerations for clinical trials in this region.
Learn how Pharm-Olam handled challenges such as unpredictable seasons and high patient withdrawal rates in these Birch and Grass Pollen Allergy studies.
Pharm-Olam’s experience level and proactive approach were critical in the speedy recruitment of patients for this Phase II Post Herpetic Neuralgia study.
In this eBook, we review the history of response evaluation in oncology trials as it has changed alongside technology and share our view of its future.
This eBook provides an overview of the challenges we continue to face with antibiotic and bacterial resistance.
This whitepaper explains the shortcomings of the floor-and-ceiling drug resupply method. We outline a 5-step algorithm for your clinical trial to cut costs and adhere to protocols.
India's regulatory environment has made it difficult to conduct clinical research. This whitepaper explores how policies have evolved in recent years.
The United States is a common site for launching Phase I-III clinical trials, but Canada offers similar prospects for trial success and should not be overlooked.
Latin America, which boasts easy access to a diverse patient population, is more conducive to conducting clinical trials than ever before. Find out more in these pages.
Despite political unrest in a small section of the country, clinical trials are thriving in Europe’s second largest country. Read our whitepaper to learn more.
Turkey is an up-and-coming location for savvy clinical trial managers. Read on for a comprehensive guide to the country’s dynamic research environment.
Belarus is a hidden gem for clinical trial managers. In these pages, you will learn about its high enrollment rates, favorable cost structure, and more.
Biopharmaceutical companies are turning toward emerging markets to reduce clinical trial costs and timelines. Here, we weigh the benefits and drawbacks.
Pharm-Olam completed enrollment using only 41 out of the 49 planned sites in this study. Find out what the sponsor had to say about the efficiency of our services.
Thanks to its large population and centralized health care system, Russia has become an excellent choice for clinical trials. Our whitepaper details why.
Pharm-Olam played an integral part in the enrollment of the additional patients in this Phase III study. Discover how we met and surpassed those goals.
Sponsors don’t expect to transfer responsibility of a trial to a new CRO—but it can be necessary. Here, we show what a successful transfer looks like.